RxDoctor Payments Data

Terry Lin, PA

Surgical · New York, NYNPI 1083996946

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $49,405 of the $69,978 with a category attached, or 70.6%. Medical Device Business Services, Inc. accounts for 77.7% of it on its own, with 10 other manufacturers making up the rest. Among surgical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$69,978in general payments, 2019–2025

Across 169 payments — averaging $414.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$54K
  • Vericel Corporation$9K
  • Johnson & Johnson$3K
  • Gotham Surgical Solutions & Devices, Inc.$1K
  • Arthrex$763
  • Suvon Surgical LLC$491
  • plus $607 from 5 others

What the payments were for

  • Consulting fees$49,40571%
  • Speaking & faculty fees$6,3009%
  • Travel & lodging$8,83213%
  • Food & beverage$4,1046%
  • Education$1,3372%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$69,978 in reported general payments places this provider in the 95th percentile of 1,544 surgical providers in New York.

See all surgical providers in New York

Medicare billing

Part B allowed, 2024
$57,322
Medicare patients
86
Services billed
4,318

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl17$89
Naproxen17$86
Tramadol Hcl20$50

Paid to pharmacies, not to this prescriber.

Other surgical in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →